Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Turner

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2012
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumorsFariba Navid, Sharyn D Baker, M Beth McCarville, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2026
Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 TrialEugene Athan, Richard N Greenberg, David A Baker, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Analytical Chemistry|March 18, 2024
A Top-Down Proteomic Assay to Evaluate KRAS4B-Compound EngagementRobert A D'Ippolito, Dana Rabara, Maria Abreu Blanco, et al.
The Journal of Arthroplasty|October 24, 2018
Hip and Knee Section, Prevention, Prosthesis Factors: Proceedings of International Consensus on Orthopedic InfectionsCraig A Aboltins, Valentin Antoci, Sanjib Bhattacharyya, et al.
Neuro-Oncology|March 25, 2017
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) studyAnuradha Banerjee, Regina I Jakacki, Arzu Onar-Thomas, et al.
The Journal of Arthroplasty|October 24, 2018
Hip and Knee Section, Prevention, Antimicrobials (Systemic): Proceedings of International Consensus on Orthopedic InfectionsCraig A Aboltins, Jan Erik Berdal, Francisco Casas, et al.
Science (New York, N.Y.)|July 15, 2017
Publish openly but responsiblyAndrew J Lowe, Anita K Smyth, Ken Atkins, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trialDavid L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
BMJ (Clinical Research Ed.)|February 14, 2023
Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trialRichard Holland, Christine Bond, David P Alldred, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2012
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumorsFariba Navid, Sharyn D Baker, M Beth McCarville, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2026
Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 TrialEugene Athan, Richard N Greenberg, David A Baker, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Analytical Chemistry|March 18, 2024
A Top-Down Proteomic Assay to Evaluate KRAS4B-Compound EngagementRobert A D'Ippolito, Dana Rabara, Maria Abreu Blanco, et al.
The Journal of Arthroplasty|October 24, 2018
Hip and Knee Section, Prevention, Prosthesis Factors: Proceedings of International Consensus on Orthopedic InfectionsCraig A Aboltins, Valentin Antoci, Sanjib Bhattacharyya, et al.
Neuro-Oncology|March 25, 2017
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) studyAnuradha Banerjee, Regina I Jakacki, Arzu Onar-Thomas, et al.
The Journal of Arthroplasty|October 24, 2018
Hip and Knee Section, Prevention, Antimicrobials (Systemic): Proceedings of International Consensus on Orthopedic InfectionsCraig A Aboltins, Jan Erik Berdal, Francisco Casas, et al.
Science (New York, N.Y.)|July 15, 2017
Publish openly but responsiblyAndrew J Lowe, Anita K Smyth, Ken Atkins, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trialDavid L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
BMJ (Clinical Research Ed.)|February 14, 2023
Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trialRichard Holland, Christine Bond, David P Alldred, et al.
Pageof 16